A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.

A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.

Item
http://www.wikidata.org/entity/Q37114366
Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.Encapsulation of poorly soluble drugs in polymer-drug conjugates: effect of dual-drug nanoformulations on cancer therapy.Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycinA 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs.Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors.PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.Solubilization of flurbiprofen into aptamer-modified PEG-PLA micelles for targeted delivery to brain-derived endothelial cells in vitro.Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.Brushed block copolymer micelles with pH-sensitive pendant groups for controlled drug delivery.Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
P2860

A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.

Item
http://www.wikidata.org/entity/Q37114366
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A cremophor-free formulation f ...... and pharmacokinetics in rats.
@en
A cremophor-free formulation for tanespimycin
@nl
type
label
A cremophor-free formulation f ...... and pharmacokinetics in rats.
@en
A cremophor-free formulation for tanespimycin
@nl
prefLabel
A cremophor-free formulation f ...... and pharmacokinetics in rats.
@en
A cremophor-free formulation for tanespimycin
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
A cremophor-free formulation f ...... and pharmacokinetics in rats.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932